Co-Diagnostics, Inc. (CODX)
USD 0.33
(2.17%)
USD 0.33
(2.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.62 Million USD | -115.39% |
| 2022 | 28.73 Million USD | -66.71% |
| 2021 | 86.31 Million USD | 48.91% |
| 2020 | 57.96 Million USD | 56424.01% |
| 2019 | 102.54 Thousand USD | 235.99% |
| 2018 | 30.52 Thousand USD | 314.67% |
| 2017 | 7360.00 USD | 119.63% |
| 2016 | -37.49 Thousand USD | -13.13% |
| 2015 | -33.14 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -389.38 Thousand USD | -24.67% |
| 2024 Q1 | -312.33 Thousand USD | -213.8% |
| 2023 FY | -4.42 Million USD | -115.39% |
| 2023 Q1 | 99.71 Thousand USD | -88.74% |
| 2023 Q2 | -261.28 Thousand USD | -362.03% |
| 2023 Q3 | 2.2 Million USD | 942.49% |
| 2023 Q4 | 274.45 Thousand USD | -87.53% |
| 2022 Q2 | 4.1 Million USD | -78.84% |
| 2022 FY | 28.73 Million USD | -66.71% |
| 2022 Q4 | 885.71 Thousand USD | -79.53% |
| 2022 Q3 | 4.32 Million USD | 5.32% |
| 2022 Q1 | 19.41 Million USD | 8.39% |
| 2021 Q1 | 16.75 Million USD | -26.63% |
| 2021 FY | 86.31 Million USD | 48.91% |
| 2021 Q4 | 17.91 Million USD | -33.13% |
| 2021 Q3 | 26.79 Million USD | 7.79% |
| 2021 Q2 | 24.85 Million USD | 48.36% |
| 2020 Q3 | 15.99 Million USD | 1.92% |
| 2020 FY | 57.96 Million USD | 56424.01% |
| 2020 Q4 | 22.83 Million USD | 42.72% |
| 2020 Q2 | 15.69 Million USD | 1371.3% |
| 2020 Q1 | 1.06 Million USD | 1813.14% |
| 2019 Q1 | 2948.00 USD | 105.87% |
| 2019 Q4 | 55.76 Thousand USD | 164.66% |
| 2019 Q2 | 22.76 Thousand USD | 672.22% |
| 2019 Q3 | 21.06 Thousand USD | -7.45% |
| 2019 FY | 102.54 Thousand USD | 235.99% |
| 2018 Q3 | 9696.00 USD | 0.0% |
| 2018 FY | 30.52 Thousand USD | 314.67% |
| 2018 Q1 | 9696.00 USD | 273.21% |
| 2018 Q2 | 9696.00 USD | 0.0% |
| 2018 Q4 | 1432.00 USD | -85.23% |
| 2017 Q4 | 2598.00 USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | 7360.00 USD | 119.63% |
| 2017 Q3 | 2598.00 USD | 20.06% |
| 2017 Q2 | 2164.00 USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 FY | -37.49 Thousand USD | -13.13% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 FY | -33.14 Thousand USD | 0.0% |
| 2015 Q4 | 10 Thousand USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -3.023% |
| BrainsWay Ltd. | 23.09 Million USD | 88.623% |
| Cerus Corporation | 86.4 Million USD | 96.959% |
| Envoy Medical, Inc. | -473 Thousand USD | 655.41% |
| electroCore, Inc. | 13.22 Million USD | 80.137% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -4206.703% |
| IceCure Medical Ltd | 1.3 Million USD | -102.084% |
| Inogen, Inc. | 126.69 Million USD | 97.927% |
| OrthoPediatrics Corp. | 111.25 Million USD | 97.639% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 143.423% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 5649.875% |
| MaxCyte, Inc. | 36.54 Million USD | 92.812% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -475.464% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2988.513% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.46% |
| PAVmed Inc | -3.96 Million USD | 166.207% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 147.896% |
| RxSight, Inc. | 53.76 Million USD | 95.114% |
| Sight Sciences, Inc. | 69.17 Million USD | 96.202% |
| SI-BONE, Inc. | 109.42 Million USD | 97.599% |
| TELA Bio, Inc. | 40.11 Million USD | 93.451% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 98.271% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 68.237% |
| Acutus Medical, Inc. | -3.13 Million USD | 183.745% |
| Talis Biomedical Corporation | 371 Thousand USD | -608.11% |
| Spectral AI, Inc. | 7.88 Million USD | 66.661% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 139.853% |
| CVRx, Inc. | 33.03 Million USD | 92.049% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -255.24% |
| Bioventus Inc. | 328.19 Million USD | 99.2% |
| Venus Concept Inc. | 52.16 Million USD | 94.964% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 83.484% |
| LivaNova PLC | 771.25 Million USD | 99.659% |
| 908 Devices Inc. | 25.32 Million USD | 89.625% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.153% |
| Nemaura Medical Inc. | -1.47 Million USD | 277.94% |
| NeuroPace, Inc. | 48.12 Million USD | 94.541% |
| LENSAR, Inc. | 21.1 Million USD | 87.553% |
| Apyx Medical Corporation | 14.12 Million USD | 81.397% |
| Cutera, Inc. | 41.49 Million USD | 93.669% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 85.77% |
| BioSig Technologies, Inc. | 18 Thousand USD | -14494.939% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 97.452% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 80.703% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.704% |
| Axonics, Inc. | 274.55 Million USD | 99.043% |
| Outset Medical, Inc. | 29 Million USD | 90.941% |
| IRIDEX Corporation | 21.8 Million USD | 87.953% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 96.302% |
| IRadimed Corporation | 50.15 Million USD | 94.762% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -815.362% |
| INVO Bioscience, Inc. | 1.08 Million USD | -141.874% |
| Telesis Bio, Inc. | 16.95 Million USD | 84.501% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 97.671% |
| Varex Imaging Corporation | 256.9 Million USD | 98.977% |
| Quipt Home Medical Corp. | 163.84 Million USD | 98.397% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 747.066% |
| Pulmonx Corporation | 50.75 Million USD | 94.824% |
| Dynatronics Corporation | 7.63 Million USD | 65.591% |
| Modular Medical, Inc. | -768 Thousand USD | 442.069% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 52.648% |
| Semler Scientific, Inc. | 61.2 Million USD | 95.707% |
| InMode Ltd. | 411.34 Million USD | 99.361% |
| Bruker Corporation | 1.51 Billion USD | 99.827% |
| Cytosorbents Corporation | 22.39 Million USD | 88.268% |
| DexCom, Inc. | 2.28 Billion USD | 99.885% |
| Align Technology, Inc. | 2.71 Billion USD | 99.903% |
| Viveve Medical, Inc. | 620 Thousand USD | -323.724% |
| ZimVie Inc. | 290.38 Million USD | 99.095% |
| Movano Inc. | -158 Thousand USD | 1762.715% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 97.599% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2988.513% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.286% |
| Profound Medical Corp. | 4.51 Million USD | 41.802% |
| Insulet Corporation | 1.15 Billion USD | 99.774% |
| enVVeno Medical Corporation | -546 Thousand USD | 581.152% |
| Surmodics, Inc. | 93.05 Million USD | 97.177% |
| iCAD, Inc. | 14.53 Million USD | 81.927% |
| Nuwellis, Inc. | 4.98 Million USD | 47.279% |
| Biotricity, Inc. | 8.35 Million USD | 68.562% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.208% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 831.663% |
| InspireMD, Inc. | 1.8 Million USD | -45.384% |
| PAVmed Inc. | -3.96 Million USD | 166.207% |
| BIOLASE, Inc. | 16.72 Million USD | 84.292% |
| Beyond Air, Inc. | -1.3 Million USD | 301.001% |
| FONAR Corporation | 45.14 Million USD | 94.18% |
| AxoGen, Inc. | 127.87 Million USD | 97.946% |
| Vivani Medical, Inc. | -357 Thousand USD | 835.879% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 98.654% |
| Inari Medical, Inc. | 434.56 Million USD | 99.395% |
| UFP Technologies, Inc. | 112.22 Million USD | 97.659% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -20884.815% |
| Tenon Medical, Inc. | 1.24 Million USD | -111.691% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 3343.32% |
| AdaptHealth Corp. | 479.56 Million USD | 99.452% |
| Sintx Technologies, Inc. | 1.84 Million USD | -42.544% |
| NanoVibronix, Inc. | 1.53 Million USD | -70.923% |
| Quanterix Corporation | 70.64 Million USD | 96.281% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 747.066% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 81.315% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 95.023% |
| TransMedics Group, Inc. | 154.09 Million USD | 98.295% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 41.004% |
| NeuroMetrix, Inc. | 3.94 Million USD | 33.448% |
| Hyperfine, Inc. | 4.75 Million USD | 44.774% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 97.544% |
| Biomerica, Inc. | 611 Thousand USD | -329.965% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 93.698% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 436.394% |
| Silk Road Medical, Inc | 127.08 Million USD | 97.933% |